Get started
Author

R. Westhovens

Survival, comorbidities and joint damage 11 years after the COBRA combination therapy trial in early rheumatoid arthritis
2009 · Lilian H D van Tuyl, Maarten Boers, et al. · Annals of the Rheumatic Diseases · 123
Daily practice effectiveness of a step-down treatment in comparison with a tight step-up for early rheumatoid arthritis
2007 · P. Verschueren, G. Esselens, et al. · Lara D. Veeken · 76
Low dose corticosteroid associated osteoporosis in rheumatoid arthritis and its prophylaxis and treatment: bones of contention.
1995 · J Dequeker, R Westhovens · PubMed · 36
Optimal care for early RA patients: the challenge of translating scientific data into clinical practice
2011 · P. Verschueren, R. Westhovens · Lara D. Veeken · 24
An unusual non-traumatic atlantoaxial subluxation in an adult patient: Grisel?s syndrome
2004 · L. Corluy, L. Pison, et al. · Clinical Rheumatology · 7
Ab0421 Real-world Effectiveness of Upadacitinib in Patients With Rheumatoid Arthritis
2023 · D.C. Diederik, P. Durez, et al. · Annals of the Rheumatic Diseases · 6
PDF
Belgian rheumatologists' perception on eligibility of RA patients for anti-TNF treatment matches more closely Dutch rather than Belgian reimbursement criteria
2008 · E. Geens, P. Geusens, et al. · Lara D. Veeken · 5
SAT0454 Determinants of delay between onset of symptoms and initiation of treatment in a belgian RA population
2012 · D. De Cock, R. Westhovens, et al. · Annals of the Rheumatic Diseases · 3
Rheumatic Disorders and Glucocorticoid-Induced Osteoporosis
2002 · J. Dequeker, R. Westhovens, et al. · KARGER eBooks · 2
Op0287-hpr One-in-three Patients With Rheumatoid Arthritis Report Clinically Important Worsening on the Rheumatoid Arthritis Impact of Disease (raid) Between Clinic Visits: Engagement and Patient-reported Outcome Results From a Smartphone App for Patient Education and Remote Monitoring
2024 · M. Doumen, E. De Meyst, et al. · Annals of the Rheumatic Diseases · 1
Ab0525 Early Responders to Remission-induction Treatment With Methotrexate and Bridging Glucocorticoids Report Lower Rheumatoid Arthritis Impact of Disease (raid) Over 2 Years: Secondary Analysis of the Carera2020 Trial
2024 · M. Doumen, D. Bertrand, et al. · Annals of the Rheumatic Diseases · 1
POS0694 WHAT TREATMENT GIVES THE BEST CLINICAL RESPONSE AFTER CESSATION OF JAKi THERAPY IN PATIENTS WITH RA? DATA OF THE TARDIS-RA REGISTRY, A NATIONWIDE BELGIAN BIOLOGIC REGISTRY
2022 · D. De Cock, P. Durez, et al. · Annals of the Rheumatic Diseases · 1
PDF
POS0207 UNRAVELING THE COMPLEX INTERACTION BETWEEN DISEASE ACTIVITY AND FATIGUE IN EARLY RA: A MEDIATION ANALYSIS WITH DATA FROM THE CareRA TRIAL
2022 · M. Doumen, S. Pazmino, et al. · Annals of the Rheumatic Diseases · 1
PDF
Op0330 One-in-three Patients With Early Rheumatoid Arthritis Experience Persistent Disease Impact Despite Control of Inflammation: a Longitudinal Trajectory Analysis of Two Randomized Controlled Trials.
2025 · M. Doumen, N. Degryse, et al. · Annals of the Rheumatic Diseases
Pos1466-hpr Unmet Needs in Patients With Rheumatoid Arthritis Judged in Remission by the Rheumatologist: a Semi-structured Interview Study
2025 · E. De Meyst, M. Piessens, et al. · Annals of the Rheumatic Diseases
Pos0596 Speed and Stability of Disease Control in Early Rheumatoid Arthritis After Remission-induction Treatment With Methotrexate and Bridging Glucocorticoids: Secondary Outcomes of the Carera2020 Trial
2024 · D. Bertrand, J. Joly, et al. · Annals of the Rheumatic Diseases
POS1039 REAL-WORLD EFFECTIVENESS OF UPADACITINIB AND TNFi IN PATIENTS WITH RHEUMATOID ARTHRITIS
2024 · D.C. Diederik, P. Durez, et al. · Annals of the Rheumatic Diseases
OP0032 AN ECONOMIC WINDOW OF OPPORTUNITY FOR PATIENTS WITH EARLY RHEUMATOID ARTHRITIS: 5-YEAR COST-EFFECTIVENESS ANALYSIS OF THE CareRA TRIAL
2022 · S. Pazmino, V. Stouten, et al. · Annals of the Rheumatic Diseases
PDF
Ab1395 Patients' and Rheumatologists' Perceptions Regarding Tapering of Rituximab
2022 · D. Bertrand, A. Deprez, et al. · Annals of the Rheumatic Diseases
PDF
Ab1394 On-flare Retreatment With Rituximab in Rheumatoid Arthritis: Patients' and Rheumatologists' Perceptions
2022 · D. Bertrand, A. Deprez, et al. · Annals of the Rheumatic Diseases
PDF
Ab0400 a Systematic Literature Review and Meta-analysis Into the Success Rate of Glucocorticoid Discontinuation After Their Use as Initial Bridging Therapy in Rheumatoid Arthritis Patients in Observational Cohorts and Clinical Trials
2022 · L. van Ouwerkerk, A. Palmowski, et al. · Annals of the Rheumatic Diseases
PDF
POS0523 FATIGUE TRAJECTORIES IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS: A LONGITUDINAL ANALYSIS OF DATA FROM THE CareRA TRIAL
2022 · M. Doumen, S. Pazmino, et al. · Annals of the Rheumatic Diseases
PDF
POS0240 WHICH FACTORS DRIVE THE CHOICE BETWEEN A 1ST AND 2ND GENERATION tsDMARD THERAPY IN RA THERAPY?
2022 · D. De Cock, P. Durez, et al. · Annals of the Rheumatic Diseases
PDF
156. Preliminary Validation of an Illness Perception Questionnaire for Healthcare Professionals
2015 · Seher Arat, Anke Van den Zegel, et al. · Lara D. Veeken
Book reviews
1997 · R. Westhovens, J. M. Mbuyi-Muamba, et al. · Clinical Rheumatology
Works count: 29
Citation count: 286
H-index: 6
I10-index: 4
Year
Topic
Type